FERAGALLI, Beatrice
 Distribuzione geografica
Continente #
NA - Nord America 4.641
AS - Asia 3.265
EU - Europa 2.937
SA - Sud America 621
OC - Oceania 49
AF - Africa 43
Continente sconosciuto - Info sul continente non disponibili 8
AN - Antartide 1
Totale 11.565
Nazione #
US - Stati Uniti d'America 4.546
SG - Singapore 1.340
CN - Cina 860
IE - Irlanda 563
IT - Italia 516
BR - Brasile 513
UA - Ucraina 394
SE - Svezia 363
TR - Turchia 329
GB - Regno Unito 264
VN - Vietnam 228
DE - Germania 213
FR - Francia 176
IN - India 140
RU - Federazione Russa 93
HK - Hong Kong 88
FI - Finlandia 70
ES - Italia 55
CA - Canada 47
AU - Australia 46
AR - Argentina 45
AT - Austria 39
ID - Indonesia 35
PL - Polonia 33
NL - Olanda 31
BE - Belgio 30
JP - Giappone 30
BD - Bangladesh 27
TW - Taiwan 27
EC - Ecuador 26
MX - Messico 26
PT - Portogallo 25
IR - Iran 24
TH - Thailandia 24
KR - Corea 21
MY - Malesia 21
ZA - Sudafrica 20
CZ - Repubblica Ceca 15
IQ - Iraq 14
PK - Pakistan 11
CO - Colombia 10
RO - Romania 10
CH - Svizzera 9
PY - Paraguay 8
CL - Cile 7
EU - Europa 7
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
BG - Bulgaria 6
LT - Lituania 6
HR - Croazia 5
IL - Israele 5
PA - Panama 5
VE - Venezuela 5
DO - Repubblica Dominicana 4
DZ - Algeria 4
EE - Estonia 4
MA - Marocco 4
NI - Nicaragua 4
UY - Uruguay 4
EG - Egitto 3
GR - Grecia 3
JM - Giamaica 3
KE - Kenya 3
NZ - Nuova Zelanda 3
OM - Oman 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
AZ - Azerbaigian 2
BO - Bolivia 2
DK - Danimarca 2
GT - Guatemala 2
JO - Giordania 2
KW - Kuwait 2
KZ - Kazakistan 2
LU - Lussemburgo 2
ME - Montenegro 2
MM - Myanmar 2
NG - Nigeria 2
PH - Filippine 2
PS - Palestinian Territory 2
QA - Qatar 2
SA - Arabia Saudita 2
SC - Seychelles 2
SV - El Salvador 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AQ - Antartide 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CG - Congo 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
HU - Ungheria 1
KG - Kirghizistan 1
KH - Cambogia 1
LK - Sri Lanka 1
MC - Monaco 1
MD - Moldavia 1
NO - Norvegia 1
NP - Nepal 1
Totale 11.561
Città #
Singapore 966
Chandler 659
Jacksonville 576
Dublin 547
Princeton 254
Dallas 244
Ashburn 235
Beijing 197
Izmir 166
Nanjing 165
Santa Clara 150
Southend 127
Los Angeles 124
Wilmington 117
Altamura 104
The Dalles 103
Ho Chi Minh City 93
New York 91
Cambridge 83
Ann Arbor 74
Hong Kong 69
Dearborn 67
Nanchang 60
Chieti 56
Hanoi 53
Redondo Beach 49
Boardman 47
São Paulo 37
Tongling 37
Buffalo 35
Kunming 33
Munich 33
Shenyang 31
Catania 30
Hebei 29
Seattle 28
Menlo Park 26
Milan 26
Tianjin 25
Falls Church 24
Brussels 22
Denver 22
Tokyo 22
Woodbridge 22
Houston 21
Jiaxing 21
Frankfurt am Main 20
Rio de Janeiro 20
Washington 20
Chennai 19
Santa Pola 19
Sydney 18
Brooklyn 17
Hangzhou 17
Istanbul 17
Norwalk 17
Vienna 17
Warsaw 17
Kuala Lumpur 16
Toronto 16
London 15
Orem 15
Shanghai 15
Amsterdam 14
Changsha 14
Curitiba 14
Helsinki 14
Pescara 14
Atlanta 13
Da Nang 13
Johannesburg 13
Montreal 13
Nuremberg 13
Stoke-on-Trent 13
Taichung 13
Calpe 12
Chicago 12
Guangzhou 12
Phoenix 12
Rome 12
San Jose 12
Taipei 12
Manchester 11
Ankara 10
Columbus 10
Lanzhou 10
Poplar 10
Stockholm 10
Bengaluru 9
Guayaquil 9
Jakarta 9
Waidhofen An Der Ybbs 9
Boston 8
Brno 8
Hefei 8
Melbourne 8
Namur 8
New Delhi 8
Pune 8
Quito 8
Totale 6.701
Nome #
Supplementary prevention and management of asthma with quercetin phytosome: a pilot registry 398
Pycnogenol® supplementation prevents inflammation and symptoms in recurrent, non-severe urinary infections 190
Cone beam computed tomography for dental and maxillofacial imaging: technique improvement and low-dose protocols 160
Pulmonary nodule [Il nodulo polmonare] 157
Effects of collagen remodulation with Centella asiatica (Centellicum®) in Dupuytren palmar fibromatosis: a pilot supplement study 155
[Possibility of false negative results in the diagnosis of lung neoplasms with computerized tomography] 154
Effects of different doses of Pycnogenol® on plasma oxidative stress: A pilot, supplement study 151
Robuvit® (Quercus robur extract) supplementation in subjects with chronic fatigue syndrome and increased oxidative stress. A pilot registry study 147
Aescin and microcirculatory activity. Effects of accessory components on clinical and microcirculatory efficacy. 144
Long-haul flights, edema, and thrombotic events: prevention with stockings and Pycnogenol® supplementation (LONFLIT Registry Study). 137
The lung in systemic vasculitis: Radiological patterns and differential diagnosis 135
Biomechanical aspects in late implant failures: Scanning electron microscopy analysis of four clinical cases 132
Moderate, diffuse, somatic muscular pain: Effects of supplementation with a Pycnogenol patch 126
Pycnogenol® and Centella asiatica to prevent asymptomatic atherosclerosis progression in clinical events 126
An open, supplement, registry study Arborvitae (R) for prevention of arthrosis-related pain during exercise 125
Management of Varicose Veins and Chronic Venous Insufficiency in a Comparative Registry with Nine Venoactive Products in Comparison with Stockings 120
Mononucleosis-related fatigue: supplementary management with Robuvit®. 119
Effects of pycnogenol on endothelial dysfunction in borderline hypertensive, hyperlipidemic, and hyperglycemic individuals: the borderline study. 118
Anatomical features of cephalothoracopagus variations: CT and MRI. 117
TECA (Titrated Extract of Centella Asiatica): new microcirculatory, biomolecular, and vascular application in preventive and clinical medicine. A status paper. 115
Management of functional, hepatic damage after chemotherapy with Liverubin (pharma-standard silymarin). 115
Bilberry extracts are not created equal: the role of non anthocyanin fraction. Discovering the "dark side of the force" in a preliminary study 114
Temporary kidney dysfunction: Robuvit® supplementation in initial, transient kidney insufficiency and micro-macro albuminuria 113
Aescin: microcirculatory activity. Effects of accessory components on clinical and microcirculatory efficacy. 112
Arterial Thrombosis in ambulatory cancer patients treated with chemotherapy. 112
Pycnogenol® supplementation improves the control of irritable bowel syndrome symptoms. 111
Thyroid cysts treatment with the sclerosing agent Atossiclerol. Long-term (5 to 15 years) follow-up. 110
Valutazione dell'area valvolare aortica (AVA): confronto fra risonanza cardiaca (RCM), ecocardiografiatranstoracia (ETT) e transesofagea (ETE) 108
Management of mild, primary Raynaud Syndrome: supplementation with Pycnogenol (R) 107
Exploring the concept of vigor and dys-vigor in men of 50-65 years: effects of Robuvit® 107
Assessment of aortic valve area (AVA) by cardiac magnetic resonance (CMR) imaging in comparison with transthoracic (TTE) and transesophageal echocardiography (TEE) 106
A natural pharma standard supplement formulation to control treatment-related toxicity and oxidative stress in genitourinary cancer: a preliminary study 106
Behçet syndrome: effects of Pycnogenol® supplementation during regression phases. 106
Management of symptoms, pain and mobility with supplementary managements (including Movardol Forte) in osteoarthrosis: A 6-month, morphology supplement study 106
Supplementation with a new food grade delivery system of Boswellia and Centella in the intervertebral discs registry: The Sager study 106
Activity of some physiological modulators in reducing the side effects of levothyroxine in patients suffering from primary hypothyroidism. 105
Effectiveness of a novel boswellic acids delivery form (Casperome®) in the management of grade II ankle sprains due to sport trauma - a registry study 105
Supplementary management with Pycnogenol® in Parkinson's disease to prevent cognitive impairment. 105
Supplementation with a lecithin-based delivery form of Boswellia serrata extract (Casperome®) controls symptoms of mild irritable bowel syndrome 102
Recurrence of retinal vein thrombosis with Pycnogenol® or Aspirin® supplementation: a registry study 101
Improvement of common cold with Pycnogenol®: a Winter registry study. 100
Pycnogenolà supplementation improves health risk factors in subjects with metabolic syndrome 100
Prevention of recurrent venous thrombosis and post-thrombotic syndrome. 99
Robuvit®: improvement of fatigue in medical convalescence. 99
Malignant pleural disease 98
Delayed progression of atherosclerosis and cardiovascular events in asymptomatic patients with atherosclerotic plaques; 3-year prevention with the supplementation with Pycnogenol®+Centellicum® 98
Artificial Saliva in Diabetic Xerostomia (ASDIX): Double Blind Trial of Aldiamed® Versus Placebo 98
Interaction study between antiplatelet agents, anticoagulants, diabetic therapy and a novel delivery form of quercetin. 97
Mirtogenol® supplementation in association with dorzolamide-timolol or latanoprost improves the retinal microcirculation in asymptomatic patients with increased ocular pressure 94
Supplementation with Robuvit® in subjects with burnout associated to high oxidative stress 94
Primary benign back pain: supplementation with Pycnogenol® 94
Venoruton®: post thrombotic syndrome. Clinical improvement in venous insufficiency (signs and symptoms) with Venoruton®. A five-year, open-registry, efficacy study. 93
Errors in imaging of traumatic injuries 93
7T mMR in the assessment of acute arterial mesenteric ischemia in a rat model 93
Supplementary management of functional, hepatic damage with Liverubin (pharma-standard Silymarin). A 3-month registry. 93
Pycnogenol®+Centellicum®, post-stent evaluation: prevention of neointima and plaque re-growth 93
Incidental venous thromboembolism in ambulatory cancer patients receiving chemotherapy 92
Malignant pleural disease 92
Activity of some physiological modulators in reducing the side effects of levothyroxine in patients suffering from primary hypothyroidism. 91
Ecografia toracica. Diagnosi e tecniche interventistiche 91
Non-small cell lung carcinoma. Early diagnosis: applicability of a screening 91
Small-Bowel Neoplasms: Role of MRI Enteroclysis 91
Oxidative stress following administration of levothyroxine in subjects suffering from primary hypothyroidism. 90
Radiographic evaluation of mediastinal lines as a diagnostic approach to occult or subtle mediastinal abnormalities. 90
The COFU3 Study. Improvement in cognitive function, attention, mental performance with Pycnogenol® in healthy subjects (55-70) with high oxidative stress 90
Managing ulcerative colitis in remission phase: usefulness of Casperome®, an innovative lecithin-based delivery system of Boswellia serrata extract 89
Chronic venous insufficiency and venous microangiopathy: Management with compression and Pycnogenol® 89
Supplementation with Pycnogenol® improves signs and symptoms of menopausal transition. 88
Prevention of diffuse, minimal lymphatic "retention" with Robuvit®: a concept, supplement registry study 88
Topical formulation of heparin is effective in reducing the symptoms of superficial venous thrombosis: a monocenter, observer-blind, placebo-controlled randomized study. 87
PycnoRacer®, a fitness drink including Pycnogenol®, improves recovery and training in the Cooper test 87
Pycnogenol® supplementation in minimal cognitive dysfunction 86
Recurrent retinal vein thrombosis: prevention with Aspirin, Pycnogenol®, ticlopidine, or sulodexide 86
Thrombo-prophylaxis prevents thrombotic events in home-managed COVID patients. A registry study 86
Supplementation with Pycnogenol® improves signs and symptoms of menopausal transition. 85
Pycnogenol® prevents oxidative stress and side effects in patients with hypothyroidism during levothyroxine treatment 84
Central Cardiovascular Calcifications: Supplementation With Pycnogenol® and Centellicum®: Variations Over 12 Months 84
[Severe intermittent claudication: PGE1 treatment. A 40-week registry, efficacy and costs]. 83
Osteoporosis of the jaw. Product evaluation: mf Odontovis Calcium®. 83
Supplementation with Robuvit® in post-mastectomy post-radiation arm lymphedema. 83
Assessment of ultrasound acoustic artifacts in patients with acute dyspnea: a multicenter study 83
Anthocran® Phytosome®: Prevention of Recurring Urinary Infections and Symptoms after Catheterization 83
Keloidal penile fibrosis: improvements with Centellicum® (Centella asiatica) and Pycnogenol® supplementation: a pilot registry 82
Effects of a curcumin-based supplementation in asymptomatic subjects with low bone density: a preliminary 24-week supplement study 81
Improved management of primary chronic fatigue syndrome with the supplement French oak wood extract (Robuvit®): a pilot, registry evaluation. 79
Pycnogenol® improvements in asthma management. 79
Pleural disease 79
Pulmonary nodule. 78
Thoracic ultrasound in children: evidence and drawbacks 78
Transthoracic ultrasound in the assessment of pleural and pulmonary diseases: Use and limitations 78
Xerostomia: prevention with Pycnogenol® supplementation: a pilot study. 78
A sport cream (Harpago-Boswellia-ginger-escin) for localized neck/shoulder pain 78
Potential role of curcumin phytosome (Meriva) in controlling the evolution of diabetic microangiopathy. A pilot study. 76
Gore external valve support for superficial saphenous vein incompetence: a 10-year, follow-up registry. 76
Pycnogenol®-Centellicum® supplementation improves lung fibrosis and Post-Covid-19 lung healing 76
Supplementation with high titer cranberry extract (Anthocran®) for the prevention of recurrent urinary tract infections in elderly men suffering from moderate prostatic hyperplasia: a pilot study 75
Osteoporosis of the jaw. Product evaluation: mf Odontovis Calcium®. 74
Prevention of post thrombotic syndrome with Pycnogenol® in a twelve month study. 74
Movardol® (N-acetylglucosamine, Boswellia serrata, ginger) supplementation in the management of knee osteoarthritis: preliminary results from a 6-month registry study 74
Ocular and optic nerve ischemia: recognition and treatment with intravenous prostaglandin E1. 73
Totale 10.379
Categoria #
all - tutte 48.251
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.251


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021305 0 0 0 0 0 146 22 14 28 37 28 30
2021/2022664 25 19 10 102 75 38 20 49 37 22 73 194
2022/20231.889 182 272 93 201 165 360 116 155 210 25 74 36
2023/20241.020 57 40 75 34 58 227 252 54 43 58 34 88
2024/20252.625 164 535 420 76 102 103 47 142 358 139 216 323
2025/20262.477 329 181 571 742 460 194 0 0 0 0 0 0
Totale 12.134